Jazz Pharma's sleep disorder drug gets European panel backing

Jazz Pharmaceuticals Plc's treatment for a form of sleep disorder has been recommended for approval in Europe by a panel of the European Medicines Agency (EMA), the regulator said on Friday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news